Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998051330) METHOD AND COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND OTHER CONDITIONS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/051330 International Application No.: PCT/EP1998/002998
Publication Date: 19.11.1998 International Filing Date: 13.05.1998
Chapter 2 Demand Filed: 23.11.1998
IPC:
A61K 38/31 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
31
Somatostatins
Applicants:
SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A. (S.C.R.A.S.) [FR/FR]; 51-53, rue du Docteur Blanche F-Paris, FR (AllExceptUS)
CAWTHORNE, Michael, Anthony [GB/GB]; GB (UsOnly)
LIU, Yong-Ling [GB/GB]; GB (UsOnly)
SENNITT, MATTHEW, V. [GB/GB]; GB (UsOnly)
Inventors:
CAWTHORNE, Michael, Anthony; GB
LIU, Yong-Ling; GB
SENNITT, MATTHEW, V.; GB
Agent:
LUNT, Mark, George, Francis; Dibb Lupton Alsop Fountain Precinct Balm Green Sheffield S1 1RZ, GB
Priority Data:
08/855,31113.05.1997US
Title (EN) METHOD AND COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND OTHER CONDITIONS
(FR) PROCEDE ET COMPOSITIONS POUR TRAITER L'HYPERLIPIDEMIE ET D'AUTRES ETATS PATHOLOGIQUES
Abstract:
(EN) The present invention relates to a method of treating hyperlipidemia and to reducing triacylglycerols, glycerol and cholesterol in a patient. The method includes the step of administering a therapeutically effective amount of a type-5 selective somatostatin agonist to said patient. A pharmaceutical composition comprises said agonist and such product is used in the preparation of the composition for use in treating hyperlipidemia or reducing triacylglycerols, glycerol and cholesterol in a patient's body.
(FR) Cette invention se rapporte à un procédé pour traiter l'hyperlipidémie et pour réduire la concentration de triacylglycérols, de glycérol et de cholestérol dans le corps d'un patient. Ce procédé consiste à administrer au patient une quantité thérapeutiquement efficace d'un agoniste de somatostatine sélectif de type 5. Une composition pharmaceutique comprenant cet agoniste et ce produit est utilisée dans la préparation de la composition servant à traiter l'hyperlipidémie ou à réduire la concentration de triacylglycérols, de glycérol et de cholestérol dans le corps d'un patient.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0981364US20020151500CA2289490AU1998080197